New test for heart attack may save NHS millions

A simple blood test could be used to rule out the possibility of heart attack in two-thirds of people who attend A&E with chest pains, report UK researchers.

Severe Chest Pains

The test could potentially save the NHS millions of pounds by preventing up to 400,000 unnecessary hospital admissions each year.

As reported in The Lancet, the test measures a protein called troponin, which is released from the heart when a person suffers a heart attack. A low troponin level indicates that a heart attack has not actually occurred, meaning emergency admission, testing and intervention is not necessary and the patient could in fact be cared for at home.

Jeremy Pearson, Medical Director at the British Heart Foundation, says:

A faster, more accurate diagnosis of whether chest pain is caused by a heart attack would be better for patients and save the NHS money. What’s important about this study is that the evidence shows you can quickly and confidently rule out a heart attack without compromising patient safety.”

In the UK, around 1 million people visit emergency departments as a result of chest pain. Currently, international guidelines advise that these people are admitted and tested for very high troponin levels, which can involve lengthy hospital stays and repeat testing. However, the test used in the current study is much more sensitive than the standard version, detecting troponin and much lower levels in the blood.

Using this high-sensitivity test, Anoop Shah and team from the University of Edinburgh measured troponin levels in more than 6,000 patients presenting with chest pain at four hospitals in the USA and Scotland. They assessed the negative predictive value (the probability that patients were not actually at risk) of heart attack or death due to a heart condition after 30 days, across a range of troponin concentrations.

They found that a troponin level of <5 ng/L at presentation identified 61% of people who had a very low risk of heart attack, with the threshold having a negative predictive value of 99.6% that persisted regardless of cardiovascular risk factors, age, gender and previous cardiovascular disease.

“Over the last two decades the number of hospital admissions due to chest pain has tripled. The overwhelming majority of these patients do not have a heart attack,” says Shah.

“These findings could dramatically reduce unnecessary hospital admissions and provide substantial cost savings for healthcare providers,” he concludes.

Sally Robertson

Written by

Sally Robertson

Sally has a Bachelor's Degree in Biomedical Sciences (B.Sc.). She is a specialist in reviewing and summarising the latest findings across all areas of medicine covered in major, high-impact, world-leading international medical journals, international press conferences and bulletins from governmental agencies and regulatory bodies. At News-Medical, Sally generates daily news features, life science articles and interview coverage.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, June 19). New test for heart attack may save NHS millions. News-Medical. Retrieved on October 27, 2020 from

  • MLA

    Robertson, Sally. "New test for heart attack may save NHS millions". News-Medical. 27 October 2020. <>.

  • Chicago

    Robertson, Sally. "New test for heart attack may save NHS millions". News-Medical. (accessed October 27, 2020).

  • Harvard

    Robertson, Sally. 2019. New test for heart attack may save NHS millions. News-Medical, viewed 27 October 2020,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Omega-3 rich foods improve prognosis in patients with myocardial infarction